2024 Q&A Recap

About this video

This long 2024 Q&A recap covers Yurth’s supplement philosophy, which she frames as individualized, lab-driven, and favoring balance over megadosing single pathways. She explains APOE genotypes and argues Alzheimer’s risk in APOE4 carriers relates more to brain cell-membrane fluidity and cholesterol transport, and to plasmalogens, than to amyloid alone. On heart health she urges looking beyond total cholesterol to ApoB-related ratios and lipoprotein(a), and discusses natural and drug options she uses. She calls exercise, through muscle-derived myokines, the best anti-aging intervention, presents GLP-1 medicines as a broad longevity candidate, outlines her replace-what-declines peptide philosophy covering growth-hormone, thymic, gut, pineal, and mitochondrial peptides at a topic level, and defends measured melatonin use while acknowledging debate.

Key takeaways

• Build supplements around labs and conditions, favoring homeostatic support over pathway flooding
• Interpret cholesterol through particle and ratio measures, not total cholesterol alone
• Treat exercise as a systemic drug-like signal because muscle talks to brain, bone, and liver
• Frame peptide use, in her model, as periodic replacement of declining endogenous signals with monitoring
• Hold contested tools like melatonin as clinician debates to individualize, not settled rules

Episode details: published January 9, 2025 · 283 views · 27:39 long. Summary written by Self Growth Videos from the episode itself. The longevity and peptide concepts described are Dr. Elizabeth Yurth’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Dr. Yurth is co-founder and Chief Medical Officer of the Boulder Longevity Institute, a clinic, and BLI Academy sells clinician education.

← Previous: Q&A Highlights - May 2024 · Next: Q&A Highlights: January 2025 →

All Dr. Elizabeth Yurth videos · Dr. Elizabeth Yurth profile · Boulder Longevity Institute (official site)